Your browser doesn't support javascript.
loading
Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness.
Chen, Jian; Qiu, Shizhen; Li, Wentao; Wang, Kun; Zhang, Yu; Yang, Han; Liu, Baichuan; Li, Guangfei; Li, Li; Chen, Min; Lan, Junjie; Niu, Jiahua; He, Peijie; Cheng, Lei; Fan, Gaofeng; Liu, Xin; Song, Xianmin; Xu, Chenqi; Wu, Haitao; Wang, Haopeng.
Afiliação
  • Chen J; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Qiu S; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.
  • Li W; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Wang K; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Zhang Y; CeMM, Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Yang H; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Liu B; State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
  • Li G; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Li L; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Chen M; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.
  • Lan J; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Niu J; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.
  • He P; Xiamen Shuangshi Middle School of Fujian, Xiamen, Fujian, China.
  • Cheng L; Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Fan G; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.
  • Liu X; ENT institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, China.
  • Song X; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Xu C; State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.
  • Wu H; Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. shongxm@sjtu.edu.cn.
  • Wang H; State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China. cqxu@sibcb.ac.cn.
Cell Res ; 33(5): 341-354, 2023 05.
Article em En | MEDLINE | ID: mdl-36882513
ABSTRACT
Tonic signaling of chimeric antigen receptor (CAR), i.e., the spontaneous CAR activation in the absence of tumor antigen stimulation, is considered to be a pivotal event controlling CAR-T efficacy. However, the molecular mechanism underlying the spontaneous CAR signals remains elusive. Here, we unveil that positively charged patches (PCPs) on the surface of the CAR antigen-binding domain mediate CAR clustering and result in CAR tonic signaling. For CARs with high tonic signaling (e.g., GD2.CAR and CSPG4.CAR), reducing PCPs on CARs or boosting ionic strength in the culture medium during ex vivo CAR-T cell expansion minimizes spontaneous CAR activation and alleviates CAR-T cell exhaustion. In contrast, introducing PCPs into the CAR with weak tonic signaling, such as CD19.CAR, results in improved in vivo persistence and superior antitumor function. These results demonstrate that CAR tonic signaling is induced and maintained by PCP-mediated CAR clustering. Notably, the mutations we generated to alter the PCPs maintain the antigen-binding affinity and specificity of the CAR. Therefore, our findings suggest that the rational tuning of PCPs to optimize tonic signaling and in vivo fitness of CAR-T cells is a promising design strategy for the next-generation CAR.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Idioma: En Ano de publicação: 2023 Tipo de documento: Article